Back to search
FDAFDA · Food and drugs·Recall number D-1081-2023

Tydemy (drospirenone, ethinyl estradiol and levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets 0.451 mg), packaged in 1 blister of 28 tablets each (NDC 68180-904-71) further packaged in a carton of 3 blisters (NDC 68180-904-73), Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by Lupin Limited, Pithampur (M.P.), INDIA

Published August 9, 2023 · Recall initiated: June 23, 2023

Summary

FDA records drug Class I recall D-1081-2023, published August 9, 2023 and initiated June 23, 2023. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 4,179 boxes/_ cartons per box/3 pouches each/28 blister per pouch; Lot: Lot #: L200183, Exp 1/2024; L201560, Exp 9/2024. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specification and Failed Impurities/Degradation Specifications: out of specification for inactive content ascorbic acid and MTHFRC-7impurity test

What to do

Voluntary: Firm initiated · Letter

Get an email if TYDEMY has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TYDEMY
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
USA nationwide.
UPC
0368180904717
Lot
Lot #: L200183, Exp 1/2024; L201560, Exp 9/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tydemy (drospirenone, ethinyl estradiol and levomefolate calcium tablets, 3 mg/0.03 mg/0.451 mg and levomefolate calcium tablets 0.451 mg), packaged in 1 blister of 28 tablets each (NDC 68180-904-71) further packaged in a carton of 3 blisters (NDC 68180-904-73), Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by Lupin Limited, Pithampur (M.P.), INDIA recalled?

Yes. FDA published recall D-1081-2023 on August 9, 2023. Reported hazard: Failed Stability Specification and Failed Impurities/Degradation Specifications: out of specification for inactive content ascorbic acid and MTHFRC-7impurity test

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TYDEMY. UPC: 0368180904717.